44th Annual CFS: Innovative Cancer Therapy for Tomorrow

The 44th Annual CFS: Innovative Cancer Therapy for Tomorrow is dedicated to developments in diagnostics and treatments of cancer.

Key Topics

• Strategies to identify and mitigate treatment-related adverse effects associated with solid and liquid tumor treatment approaches
• The risks and benefits of treatment regimens based on recent clinical trials across solid and liquid tumors
• Optimal therapy based on biomarker testing across multiple solid and liquid tumors
• Individual patient and disease characteristics in treatment decisions to optimally manage solid and liquid tumors

Who should Attend

Health care professionals involved or interested in the treatment/management of patients with cancer including:

• Hematologists
• Oncologists
• Nurse practitioners
• Nurses
• Radiotherapists
• Pharmacists
• Fellows
• Immunologists
• Researchers
• Physician assistants
• Case managers